Currently, no approved monoclonal antibody (mAb) therapies exist for human multiple
myeloma (MM). Here we characterized cell surface CS1 as a novel MM antigen and further …

Recent studies have underscored the role of B-cell-activating factor (BAFF), a member of the
tumor necrosis factor superfamily, in promoting the survival of malignant B cells, including …

SGN-40, a humanized immoglobulin G1 (IgG1) anti-CD40 monoclonal antibody, mediates
cytotoxicity against human multiple myeloma (MM) cells via suppression of interleukin (IL)-6–…

Aims To study the role of curcumin on glioma cells via the SHH / GLI 1 pathway in vitro and
vivo. Methods The effects of curcumin on proliferation, migration, apoptosis, SHH / GLI 1 …

The conversion efficiency and product selectivity of the electroreduction of carbon dioxide
have been largely limited by the low CO 2 solubility in aqueous solution. To relieve this …

Electrochemical reduction of CO 2 (ERC) to methane has significant economic benefits and
represents one promising solution for energy and environmental sustainability. However, …

Aims Mcl‐1, an antiapoptotic member of the Bcl‐2 family, is overexpressed in human
glioblastoma, conferring a survival advantage to tumor cells. The mechanisms underlying its …

CS1 is highly expressed on tumor cells from the majority of multiple myeloma (MM) patients
regardless of cytogenetic abnormalities or response to current treatments. Furthermore, CS1 …

Periodic surface structures with periods as small as about one-tenth of the irradiating
femtosecond (fs) laser light wavelength were created on the surface of a titanium (Ti) foil by …

Activation of the extracellular signal-regulated kinase1/2 (ERK1/2) signaling cascade mediates
human multiple myeloma (MM) growth and survival triggered by cytokines and adhesion …